Literature DB >> 18704317

Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications.

Chi Meng1, Xu'e Chen, Jiawen Li, Yan Wu, Houjun Liu.   

Abstract

In order to investigate the role of MMP-9 and TIMP-1 in the pathogenesis of systemic sclerosis, the expression of MMP-9 and TIMP-1 was immunohistochemically detected in skin lesions of the patients with diffuse cutaneous systemic sclerosis, skin lesions of the patients with limited cutaneous systemic sclerosis, and skin tissues of normal subjects. The results showed that the expression of MMP-9 in lesions of diffuse cutaneous systemic sclerosis was significantly lower than that of normal skins (P<0.05). However, no significant difference in the level of MMP-9 in the limited cutaneous systemic sclerosis and normal skin was found. Meanwhile, the expression of TIMP-1 in lesions of diffuse cutaneous systemic sclerosis and limited cutaneous systemic sclerosis were significantly higher than that of normal skins (both P<0.05). It was suggested that the expression of MMP-9 and TIMP-1 might play an important role in the development of systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704317     DOI: 10.1007/s11596-008-0424-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

1.  Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

2.  Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts.

Authors:  K Kikuchi; T Kadono; M Furue; K Tamaki
Journal:  J Invest Dermatol       Date:  1997-03       Impact factor: 8.551

Review 3.  Matrix metalloproteinases as mediators of reproductive function.

Authors:  D L Hulboy; L A Rudolph; L M Matrisian
Journal:  Mol Hum Reprod       Date:  1997-01       Impact factor: 4.025

4.  Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.

Authors:  S A Jimenez; G Feldman; R I Bashey; R Bienkowski; J Rosenbloom
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

5.  Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.

Authors:  S A Young-Min; C Beeton; R Laughton; T Plumpton; S Bartram; G Murphy; C Black; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

6.  Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases.

Authors:  C J Jackson; M Nguyen
Journal:  Int J Biochem Cell Biol       Date:  1997-10       Impact factor: 5.085

7.  Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis.

Authors:  N Yazawa; K Kikuchi; H Ihn; M Fujimoto; M Kubo; T Tamaki; K Tamaki
Journal:  J Am Acad Dermatol       Date:  2000-01       Impact factor: 11.527

8.  Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.

Authors:  K Kikuchi; M Kubo; T Hoashi; K Tamaki
Journal:  Clin Exp Dermatol       Date:  2002-06       Impact factor: 3.470

9.  The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.

Authors:  E Toubi; A Kessel; G Grushko; E Sabo; M Rozenbaum; I Rosner
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

10.  Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.

Authors:  Wan-Uk Kim; So-Youn Min; Mi-La Cho; Kyung-Hee Hong; Yong-Joo Shin; Sung-Hwan Park; Chul-Soo Cho
Journal:  Arthritis Res Ther       Date:  2004-11-10       Impact factor: 5.156

View more
  2 in total

Review 1.  Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis.

Authors:  Ludivine Doridot; Mohamed Jeljeli; Charlotte Chêne; Frédéric Batteux
Journal:  Redox Biol       Date:  2019-01-25       Impact factor: 11.799

2.  Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis.

Authors:  Benjamin E Decato; Ron Ammar; Lauren Reinke-Breen; John R Thompson; Anthony V Azzara
Journal:  Rheumatology (Oxford)       Date:  2022-04-11       Impact factor: 7.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.